u/jarno_cabrera

Increases in heart rate have been reported across this receptor class. The magnitude and clinical significance are exactly what phase 3 is powered to establish.

The template is vendor, compound, batch, service, claim, result, and who paid. Every one of those fields exists because a result missing it has been argued about here before.

Went looking for independent results on Hangzhou Meite Bio after seeing them named three times in a week.

milan_villalobos has the group-buy risk right — it is structural, not a judgement about anybody in particular.

That is an accusation about a named individual and it does not belong here in any form.

Inter-lab variance on this assay runs roughly a point either way, driven mostly by gradient and integration. Two results inside that band agree; they do not disagree quietly.

I would not treat one pharmacy’s quote as the national price. Variation between them is substantial.

Registration by the therapeutic goods regulator establishes that a product may be supplied.

Disagreeing with this bit: that advice predates the change in compounded arrangements.

Sent a test amount first on a large order. Cost me a fraction of a percent and I have done it every time since.

Are you quoting advice from before the compounded arrangements changed?

Same read. The energy-expenditure mechanism is the interesting bit and it is not established in humans at scale.

network and address, checked twice, before anything else

I would not treat one pharmacy’s quote as the national price. Variation between them is substantial.

a shop that will only talk off-platform has told you something

This is the check that catches most of it, and it takes under a minute.

It is a triple agonist at the GLP-1, GIP and glucagon receptors. The glucagon arm is the genuinely novel component and it is the one with the least human outcome data behind it.

Area percent or net peptide content?

Never name an individual. The sidebar rule exists because the cost of being wrong falls on a person and the benefit of being right falls on nobody in particular.

Did the address you sent to match the one you were given, character for character?

Kept every report as a PDF with the batch in the filename. Two years in, it is the most useful folder I own.

confirmations are the only status that means anything

Agreed on the no-names rule. It protects the board and it protects people who turn out to be wrong.

Nothing containing this compound is approved anywhere. Research-use-only material is not approved for human use, and that is a statement of fact rather than a disclaimer.

The directory deliberately separates "we have nothing on this name" from "this went badly". Collapsing the two is how boards like this generate false certainty.

Phase 2 estimates effect and finds a dose range. Phase 3 estimates it precisely in a bigger population and catches what phase 2 was too small to see. Treating them as the same tier of evidence is the recurring error here.

Correcting myself upthread: it was 2 confirmations, not the number I posted, and it settled fine.

Confirmations are the count of blocks built on top of the one containing your transaction. Until there are some, the transaction is not settled in any meaningful sense.

the TGA shortage database is public and it is the source, not the news

This. The phase 2 result was genuinely large and it was also 48 weeks in a few hundred people.

The thing that surprised me was how much of the discussion here is inference rather than measurement.

nothing here is available as a prescription product, so read every thread with that in mind

Push back: an unconfirmed transaction is not a missing payment. Wait for confirmations before escalating.

Right, and a point or two between services is ordinary. It is agreement, and every month somebody posts it as a scandal.

Not convinced. That fee is the network fee at that hour, and it has nothing to do with the supplier.

Cosigning on keeping the hash. It is the only receipt in existence and people screenshot their balance instead.

private script pricing varies by pharmacy here too

Pharmacy-level availability and national supply are different questions: a pharmacy can be out while the wholesaler is not, and the pharmacist can check in minutes.

quote expiry is a real thing, not a pressure tactic

Correction: TRIUMPH is the phase 3 programme. The number you are quoting is from the phase 2 readout, which is a different trial.

the review page nobody can find on any other site is a warning

This is the check that catches most of it, and it takes under a minute.

Cosigning on saying who paid. It is the whole basis on which this log is worth anything.

Yes — gas is the network’s, not the supplier’s, and conflating them produces a lot of unfair complaints.